title: Atypical drug-induced hypersensitivity syndrome with human herpesvirus 6 reactivation due to calcium blockers.
authors.forename: Maki
authors.initials: M
authors.lastname: Moriya
authors.forename: Michiko
authors.initials: M
authors.lastname: Aihara
authors.forename: Michiru
authors.initials: M
authors.lastname: Imai
authors.forename: Yuko
authors.initials: Y
authors.lastname: Ikezawa
authors.forename: Setsuko
authors.initials: S
authors.lastname: Matsukura
authors.forename: Takeshi
authors.initials: T
authors.lastname: Kanbara
authors.forename: Yasuhisa
authors.initials: Y
authors.lastname: Baba
authors.forename: Zenro
authors.initials: Z
authors.lastname: Ikezawa
mesh_terms: D000368:Aged; D001383:Azetidinecarboxylic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D002121:Calcium Channel Blockers / Q000009:adverse effects*; D004095:Dihydropyridines / Q000009:adverse effects*; D063926:Drug Hypersensitivity Syndrome / Q000150:complications*; D015654:Herpesvirus 6, Human / Q000187:drug effects*; D006801:Humans; D008297:Male; D019349:Roseolovirus Infections / Q000139:chemically induced*; D014775:Virus Activation / Q000187:drug effects
chemical_list: D002121:Calcium Channel Blockers; D004095:Dihydropyridines; D001383:Azetidinecarboxylic Acid; C061679:azelnidipine